abstract |
The present invention relates to a novel compound of the general formula (I), an ototoxin inhibitor, a process for its preparation, pharmaceutical compositions and medicaments containing it, and its use in the treatment of ATX-dependent or ATX-mediated diseases or conditions. (I) |